Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

49 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Completed

Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products

NCT02976753

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Swedish Orphan Biovitrum Research site Innsbruck, Austria
  • Swedish Orphan Biovitrum Research site Linz, Austria
  • Swedish Orphan Biovitrum Research Site Sankt Pölten, Austria
  • Swedish Orphan Biovitrum Research site Vienna, Austria
View all 36 locations
View Trial Details
Completed

A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B

NCT03055611

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Swedish Orphan Biovitrum Reserach site Berlin, Germany
  • Swedish Orphan Biovitrum Reserach Site Blaubeuren Abbey, Germany
  • Swedish Orphan Biovitrum Research Site Bonn, Germany
  • Swedish Orphan Biovitrum Research Site Delmenhorst, Germany
View all 22 locations
View Trial Details
Completed

A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France

NCT03655340

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Swedish Orphan Biovitrum Research Site (CHU de Bordeaux) Bordeaux, France
  • Swedish Orphan Biovitrum Research Site Brest, France
  • Swedish Orphan Biovitrum Research Site Caen, France
  • Swedish Orphan Biovitrum Research Site Chambéry, France
View all 18 locations
View Trial Details
Completed

Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma

NCT01183949

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Faber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Centre New York, United States
View Trial Details
Completed

Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B

NCT03276130

Conditions
Anxiety Disorders, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +16 more
Locations
  • Swedish Orphan Biovitrum Research Site Copenhagen, Denmark
  • Swedish Orphan Biovitrum Research Site Helsinki, Finland
  • Swedish Orphan Biovitrum Research Site Gothenburg, Sweden
  • Swedish Orphan Biovitrum Research Site Malmö, Sweden
View Trial Details
Completed

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

NCT03734588

Conditions
Adeno-Associated Virus (AAV), Blood Coagulation Disorder, Blood Coagulation Disorders, +18 more
Locations
  • Orthopaedic Institute for Children Los Angeles, California, United States
  • Illinois Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Mississippi Center for Advanced Medicine Madison, Mississippi, United States
View Trial Details
Completed

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

NCT03876301

Conditions
Blood Coagulation Disorder, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +9 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • University of Florida Gainesville, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Children's Hospital of Michigan Detroit, Michigan, United States
View Trial Details

Related conditions